论文信息 - OP0019 BIMEKIZUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 2, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY - 字舞流文

OP0019 BIMEKIZUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 2, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY

M. Dougados | D. M. van der Heijde | L. Gensler | M. Oortgiesen | F. E. Van den Bosch | N. Haroon | D. Poddubnyy | T. Tomita | X. Baraliakos | A. Deodhar | C. Fleurinck | M. Brown | A. Marten | T. Vaux | H. Xu